SENSEX NIFTY
Mar 28, 2013, 12.06 PM IST | Source: Moneycontrol.com

Aurobindo Pharma jumps as FDA removes Unit VI import ban

Shares of Aurobindo Pharma surged more than 8 percent on Thursday after it said the US Food and Drug Administration has lifted the import alert for non-sterile products manufactured in its unit VI cephalosporin facility in Hyderabad, Andhra Pradesh.

Moneycontrol Bureau

Shares of Aurobindo Pharma surged more than 8 percent on Thursday after it said the US Food and Drug Administration has lifted the import alert for non-sterile products manufactured in its unit VI cephalosporin facility in Hyderabad, Andhra Pradesh.

This will pave the way for resuming exports of 9 products to the US market from the plant, the drug maker said.

The production facility that makes the anti-bacterial drug was audited by the USFDA in December 2010 and the drug regulator had issued an import alert in Feb 2011.

The unit had annual sales of USD 33 million prior to the import alert, Aurobindo said.

At 11:45 hrs, Aurobindo shares were up 8.9 percent at Rs 142.10 on NSE.

Aurobindo Pharm stock price

On September 12, 2014, Aurobindo Pharma closed at Rs 895.15, up Rs 31.25, or 3.62 percent. The 52-week high of the share was Rs 897.90 and the 52-week low was Rs 171.00.


The company's trailing 12-month (TTM) EPS was at Rs 48.78 per share as per the quarter ended June 2014. The stock's price-to-earnings (P/E) ratio was 18.35. The latest book value of the company is Rs 137.67 per share. At current value, the price-to-book value of the company is 6.50.

Set email alert for

ADS BY GOOGLE

video of the day

FY15 loan book may grow 25%; NIMs to improve: YES Bank CFO

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.